DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Eli Lilly joins TrumpRx with Zepbound + Mounjaro at $549/mo cash. Plus: FDA Q1 enforcement actions, Hims settlement aftermath, and three new compounders we are watching.
TrumpRx expanded its formulary this week to include Lilly's Zepbound and Mounjaro at $549/mo cash pricing — the same price as LillyDirect. Patients in 38 states now have two cash-pay channels. We mapped insurance carve-outs by state and confirmed the price match with Lilly customer service before publishing.